Theriva Biologics
Price & Volume
Stats
See more52W Range | $1.14-$17 |
Market Cap | $3.1M |
Shares Short | 90,953 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$32.59 |
News
See moreYahoo Finance • last year
Theriva™ Biologics and Sant Joan de Déu-Barcelona Children’s Hospital Advance Strategic Collaboration to Explore the Combination of VCN-01 with Topoisomerase Inhibitors to Treat Cancer
Yahoo Finance • last year
Theriva™ Biologics y el Hospital Infantil Sant Joan de Déu Barcelona avanzan en su colaboración estratégica para estudiar la combinación del VCN-01 con inhibidores de la topoisomerasa para tratar el cáncer
Yahoo Finance • 2 years ago
Theriva Biologics Reports First Quarter 2023 Operational Highlights and Financial Results
About
CEO | Mr. Steven A. Shallcross CPA |
CFO | Mr. Steven A. Shallcross CPA |
Address | 9605 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 22 |
